No Data
No Data
Express News | Whitefort Capital Management- Hope to Continue to Work Constructively, Collaboratively With Arbutus Biopharma's Board on These Critical Initiatives
Express News | Whitefort Capital Management- Requested That Arbutus Biopharma's Board Explore All Strategic Options for Hepatitis B Virus (Hbv) Portfolio
Express News | Whitefort Capital Management- Requested That Arbutus Biopharma's Board Immediately Terminate Atm Program
Express News | Whitefort Capital Management-Conveyed Their View to Arbutus Biopharma's Board That Current Market Price of Shares Does Not Reflect Intrinsic Value
Express News | Whitefort Capital Management, LP - Purchased Arbutus Biopharma's Securities Based on Belief That Such Securities, When Purchased, Were Undervalued
Express News | Whitefort Capital Management, LP Reports 6.8% Stake in Arbutus Biopharma Corp as of May 2, 2024 - SEC Filing
Mcsnacks H TupackOP : No resistance